Stockholm, June 24, 2010 — NASDAQ OMX (NASDAQ:NDAQ) announced that Oasmia
Pharmaceutical AB (OASM), a Small Cap company within the Biotech sector, today
starts trading of its shares on the main market of NASDAQ OMX Stockholm. Oasmia
is the twelfth company to list on NASDAQ OMX in Europe in 2010. To view and
download pictures from today's listing ceremony please visit:
http://bit.ly/cTEgA3
Oasmia Pharmaceutical AB is based in Sweden and was founded in 1999. Oasmia
develops a new generation of pharmaceuticals with the emphasis on human and
veterinary oncology, with a vision to improve treatments of severe diseases.
For more information about Oasmia, please visit www.oasmia.com
Jenny Rosberg, Senior Vice President at NASDAQ OMX said, “We are very pleased
to welcome Oasmia to our main market, one of Europe's most liquid cash equities
markets. We look forward to supporting Oasmia in increasing their investor
visibility as well as their reach to the global capital markets.”
Julian Aleksov, CEO Oasmia commented, “We are very happy to have our share
listed today. The switch from NGM to NASDAQ OMX gives Oasmia yet another
quality mark on the importance of our research, our unique products and the
company itself. It also provides more investors with a possibility to invest in
Swedish-based pharmaceutical development.”
About NASDAQ OMX
The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers
trading, exchange technology and public company services across six continents,
with more than 3,600 listed companies. NASDAQ OMX offers multiple capital
raising solutions to companies around the globe, including its U.S. listings
market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the
U.S. 144A sector. The company offers trading across multiple asset classes
including equities, derivatives, debt, commodities, structured products and
exchange-traded funds. NASDAQ OMX technology supports the operations of over 70
exchanges, clearing organizations and central securities depositories in more
than 50 countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal
entities but describe the common offering from NASDAQ OMX exchanges in
Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more
information about NASDAQ OMX, visit http://www.nasdaqomx.com. Please follow
NASDAQ OMX on Facebook (http://www.facebook.com/nasdaqomx) and Twitter
(http://www.twitter.com/nasdaqomx).
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made
under the Safe Harbor provisions of the Private Securities Litigation Reform
Act of 1995. These statements include, but are not limited to, statements about
NASDAQ OMX's products and offerings. We caution that these statements are not
guarantees of future performance. Actual results may differ materially from
those expressed or implied in the forward-looking statements. Forward-looking
statements involve a number of risks, uncertainties or other factors beyond
NASDAQ OMX's control. These factors include, but are not limited to factors
detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed
with the U.S. Securities and Exchange Commission. We undertake no obligation to
release any revisions to any forward-looking statements.
- # -
CONTACTS:
The NASDAQ OMX Group, Inc.
Anna Rasin
+46 8 405 66 12
anna.rasin@nasdaqomx.com
